Stem cell treatment after heart attack
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if umbilical cord stem cells, given alongside standard care, can help people who have had a major heart attack (STEMI). The cells are infused into the heart artery to possibly improve heart function. You may qualify if you are between 20 and 76, had a heart attack within the last 12 hours, and received a stent, and your heart's pumping ability is moderately reduced.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 to 75 years old.
- You had a type of heart attack called STEMI within the past 12 hours and got a stent placed.
- Your heart's left ventricle pumps out between 30% and 49% of its blood (LVEF).
- Your vital signs (like blood pressure and heart rate) are stable before the infusion.
- Your lung function is good (FEV1 > 50% predicted and oxygen level at least 95% on room air).
- You have adequate blood cell counts and liver/kidney function (no severe organ problems).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new stem cell treatment (HeXell-2020) for people with stable coronary artery disease. It aims to see if it's safe and can improve heart function. You may be eligible if you have stable angina and are on regular heart medications.
This trial tests whether stem cells from donated umbilical cord blood can improve heart function in people with heart failure caused by blocked arteries. You'll receive one or more infusions of these cells through a vein.
This study tests an experimental cell therapy called MiSaver that may help heart muscle recover after a heart attack. It's for people whose hearts are weak and who cannot have usual procedures like stents or bypass surgery.
This Phase 1 study tests a treatment made from stem cells to grow heart muscle cells (“cardiomyocytes”) for people with long-lasting (chronic) heart weakness after a prior heart attack. It aims to see if the therapy can improve heart function and is safe in carefully selected patients.
This study tests a new treatment using donor stem cells injected into the heart during scheduled bypass surgery. The goal is to see if these cells help improve heart function in people with heart failure due to blocked arteries and a weak heart pump.
This trial tests a treatment made from stem cells that are turned into heart muscle cells and injected directly into the heart. It is for people with advanced heart failure who are already on the best available medicines and who are scheduled to have bypass surgery.
Hear when a new ST Elevation Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.